Cargando…

High detection rate in [(18)F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients

OBJECTIVE: (18)F-labeled prostate-specific membrane antigen (PSMA) ligand, [(18)F]PSMA-1007, has the benefit of a higher synthetic yield and minimal excretion in the urine. High detection efficacy was reported in biochemical recurrence (BCR) of prostate cancer after radical prostatectomy. Thus, we e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watabe, Tadashi, Uemura, Motohide, Soeda, Fumihiko, Naka, Sadahiro, Ujike, Takeshi, Hatano, Koji, Sasaki, Hidetaka, Kamiya, Takashi, Shimosegawa, Eku, Kato, Hiroki, Cardinale, Jens, Tateishi, Ukihide, Nonomura, Norio, Giesel, Frederik L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981319/ https://www.ncbi.nlm.nih.gov/pubmed/33661475 http://dx.doi.org/10.1007/s12149-021-01602-x

Ejemplares similares

Automated [(18)F]PSMA-1007 production by a single use cassette-type synthesizer for clinical examination
por: Naka, Sadahiro, et al.
Publicado: (2020)

Duodenal Adenocarcinoma Mimicking Metastasis of Prostate Cancer on (18)F–Prostate-Specific Membrane Antigen–1007 PET/CT
por: Soeda, Fumihiko, et al.
Publicado: (2021)

Diagnostic Accuracy of (18)F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence
por: Sprute, Katharina, et al.
Publicado: (2021)

(18)F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617
por: Giesel, Frederik L., et al.
Publicado: (2016)

One-pot and one-step automated radio-synthesis of [(18)F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experiment
por: Naka, Sadahiro, et al.
Publicado: (2021)

PSMA-1007 Uptake in Ganglia of the Sympathetic Trunk and Its Intra-individual Reproducibility
por: Mamlins, E., et al.
Publicado: (2022)

Evaluation of Integrin α(v)β(3) Expression in Murine Xenograft Models: [(68)Ga]Ga-DOTA-C(RGDfK) PET Study with Immunohistochemical Confirmation
por: Mitsuyuki, Kosuke, et al.
Publicado: (2021)

Optimization of [(11)C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV
por: Isohashi, Kayako, et al.
Publicado: (2013)

Improved Stability and Practicality for Synthesis of 4-Borono-2-[(18)F]fluoro-l-phenylalanine by Combination of [(18)O]O(2) Single-Use and [(18)F]CH(3)COOF Labeling Agents
por: Naka, Sadahiro, et al.
Publicado: (2022)

Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers
por: Ujike, Takeshi, et al.
Publicado: (2022)

F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
por: Giesel, Frederik L., et al.
Publicado: (2016)

Practical calculation method to estimate the absolute boron concentration in tissues using (18)F-FBPA PET
por: Watabe, Tadashi, et al.
Publicado: (2017)

The current status of prostate cancer treatment and PSMA theranostics
por: Uemura, Motohide, et al.
Publicado: (2023)

Distribution of Intravenously Administered Acetylcholinesterase Inhibitor and Acetylcholinesterase Activity in the Adrenal Gland: (11)C-Donepezil PET Study in the Normal Rat
por: Watabe, Tadashi, et al.
Publicado: (2014)

Laparoscopic resection of aortocaval paraganglioma diagnosed by serial increase in urinary metanephrines after bilateral adrenalectomy in a patient with multiple endocrine neoplasia type 2A
por: Miyata, Yushi, et al.
Publicado: (2021)

Activated fibroblasts in muscle sarcoidosis revealed by [(18)F]FAPI-74 PET
por: Watabe, Tadashi, et al.
Publicado: (2023)

Prostate-specific membrane antigen (PSMA)–ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
por: Tateishi, Ukihide
Publicado: (2020)

FBPA PET in boron neutron capture therapy for cancer: prediction of (10)B concentration in the tumor and normal tissue in a rat xenograft model
por: Hanaoka, Kohei, et al.
Publicado: (2014)

Whole-Body Distribution of Donepezil as an Acetylcholinesterase Inhibitor after Oral Administration in Normal Human Subjects: A (11)C-donepezil PET Study
por: Mochida, Ikuko, et al.
Publicado: (2017)

Evaluation of the default-mode network by quantitative (15)O-PET: comparative study between cerebral blood flow and oxygen consumption
por: Aoe, Jo, et al.
Publicado: (2018)

Evaluation of the total distribution volume of (18)F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling
por: Romanov, Victor, et al.
Publicado: (2019)

R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy
por: Nagahara, Akira, et al.
Publicado: (2015)

Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution
por: Ujike, Takeshi, et al.
Publicado: (2016)

A novel model to predict positive prostate biopsy based on serum androgen level
por: Ujike, Takeshi, et al.
Publicado: (2017)

Correction to: Primary adrenal lymphoma: three case reports and review of Japanese cases
por: Nakazawa, Shigeaki, et al.
Publicado: (2018)

Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-(18)F-fluoro-phenylalanine (FBPA) PET study
por: Isohashi, Kayako, et al.
Publicado: (2016)

Oxygen-15 labeled CO(2), O(2), and CO PET in small animals: evaluation using a 3D-mode microPET scanner and impact of reconstruction algorithms
por: Horitsugi, Genki, et al.
Publicado: (2017)

Biokinetics and dosimetry of (18)F‐PSMA‐1007 in patients with prostate cancer
por: Hvittfeldt, Erland, et al.
Publicado: (2022)

Skeletal (18)F-PSMA-1007 uptake in prostate cancer patients
por: Janssen, Jorinde, et al.
Publicado: (2023)

Intra-Individual Comparison of Physiologic [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007 Uptake in Ganglia in Patients with Prostate Cancer: A Retrospective, Monocentric Analysis
por: Novruzov, Emil, et al.
Publicado: (2023)

Preclinical comparative study of [(18)F]AlF-PSMA-11 and [(18)F]PSMA-1007 in varying PSMA expressing tumors
por: Piron, Sarah, et al.
Publicado: (2022)

Multiparametric dynamic whole-body PSMA PET/CT using [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007
por: Dias, André H., et al.
Publicado: (2023)

PSMA-Positive Low Malignant Gastrointestinal Stromal Tumor in the Stomach on F-18-PSMA-1007 PET/CT
por: Iversen, Peter, et al.
Publicado: (2022)

Detecting and Locating the Site of Local Relapse Using (18)F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients—Potential Impact on PSMA-Guided Radiation Therapy
por: Koerber, S. A., et al.
Publicado: (2022)

Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration‐resistant prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2020)

Detection Efficacy of (18)F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
por: Giesel, Frederik L., et al.
Publicado: (2019)

Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [(18)F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model
por: Kim, Su Bin, et al.
Publicado: (2022)

Diagnostic performance of (68)Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
por: Afshar-Oromieh, Ali, et al.
Publicado: (2017)

(18)F-PSMA-1007 PET/CT uptake in multiple angiolipomas caused by PSMA expression in capillaries: a case report
por: Wang, Long, et al.
Publicado: (2021)

Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bv13qdmr7sepg0f8ft8v5kn541